metastatic breast cancer

November 9, 2020November 9, 2020

Athenex Oncology Offers Free ‘Evidenced-based’ Lifestyle Guide for MBC Patients

News

A new Athenex Oncology guide offers evidence-based lifestyle suggestions to metastatic breast cancer (MBC) patients to help improve their quality of life. The free booklet, called “Your Guide to Facing ... Read more

October 22, 2020October 22, 2020

COVID-19 Surgery Delays May Mean 2,700 More Breast Cancer Deaths Within 10 Years

News

Delays in breast cancer surgery due to the COVID-19 pandemic could cost 2,797 additional deaths in the U.S. over the next decade, according to a Kantar Health analysis. Such treatment ... Read more

April 2, 2020April 2, 2020

CytoDyn Seeks Preliminary FDA Meeting on Leronlimab’s Breakthrough Therapy Status

News

After a recommendation from the U.S. Food and Drug Administration (FDA), CytoDyn is planning to ask the regulatory agency for a preliminary meeting to discuss the granting of breakthrough therapy status ... Read more

March 20, 2020March 20, 2020

Herzuma, Biosimilar to Herceptin, Available in US for HER2-positive Breast Cancers

News

Herzuma, a biosimilar to Genentech‘s Herceptin (trastuzumab), is now available in the U.S. for the same indications as the reference therapy, including for the treatment of HER2-positive breast cancers and stomach cancers. The ... Read more

September 20, 2019September 20, 2019

FDA OKs Use of Tool to Predict Patient Response to New Form of Cisplatin in Planned Phase 3 Study

News

The U.S. Food and Drug Administration (FDA) has approved use of a device, called LiPlaCis DRP, that works to predict response to the next-generation investigational chemotherapy LiPlaCis in a planned Phase 3 ... Read more

August 23, 2019August 23, 2019

Oral Paclitaxel Combo Leads to Better Response Rates Than IV Therapy in MBC, Data Shows

News

Treatment with a combination of oral paclitaxel and encequidar led to higher and stronger response rates compared with standard paclitaxel intravenous therapy in women with metastatic breast cancer, topline data from ... Read more

July 26, 2019

FDA Approves Clinical Testing of Minerva’s CAR T-cell Therapy for Metastatic BC

News

Minerva Biotechnologies will soon start the first human trials testing its investigational therapy huMNC2-CAR44, a CAR T-cell immunotherapy intended for breast cancer that has spread to other parts of the ... Read more

July 12, 2019July 12, 2019

Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial

News

A combination of Polyphor‘s investigational therapy balixafortide (POL6326) and Eisai‘s Halaven (eribulin) may prolong the survival of women with HER2-negative metastatic breast cancer, a Phase 1 trial shows. The findings were ... Read more

July 8, 2019

Puma Applies to FDA to Extend Nerlynx’s Use to HER2-Positive Metastatic Breast Cancer

News

Puma Biotechnology is seeking to extend the use of its breast cancer medicine Nerlynx (neratinib), in combination with capecitabine, to treat women with HER2-positive breast cancer whose disease has spread ... Read more

June 14, 2019

Susan G. Komen, Cancer Australia to Co-fund Metastatic BC Research

News

A new partnership between Susan G. Komen and Cancer Australia will grant a researcher $450,000 over three years to study metastatic breast cancer. Through a Career Catalyst Research Grant provided ... Read more